Toll-like receptors 3, 4 and 9 in hepatocellular carcinoma: Relationship with clinicopathological characteristics and prognosis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Toll-like receptors 3, 4 and 9 in hepatocellular carcinoma: Relationship with clinicopathological characteristics and prognosis
Authors
Keywords
-
Journal
HEPATOLOGY RESEARCH
Volume 44, Issue 7, Pages 769-778
Publisher
Wiley
Online
2013-06-06
DOI
10.1111/hepr.12180
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
- (2012) Dianne H. Dapito et al. CANCER CELL
- Prediction of metastatic breast cancer in non-sentinel lymph nodes based on metalloprotease-1 expression by the sentinel lymph node
- (2012) Noemí Eiró et al. EUROPEAN JOURNAL OF CANCER
- Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
- (2012) Hashem B. El-Serag GASTROENTEROLOGY
- Recent advances in understanding viral evasion of type I interferon
- (2012) Kathryne E. Taylor et al. IMMUNOLOGY
- Study of the Expression of Toll-Like Receptors in Different Histological Types of Colorectal Polyps and Their Relationship with Colorectal Cancer
- (2012) Noemí Eiró et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Prognostic prediction across a gradient of total tumor volume in patients with hepatocellular carcinoma undergoing locoregional therapy
- (2011) Teh I Huo et al. BMC GASTROENTEROLOGY
- Comparative analysis of the expression of metalloproteases and their inhibitors in resected crohnʼs disease and complicated diverticular disease
- (2011) Antonio Altadill et al. INFLAMMATORY BOWEL DISEASES
- Hepatitis C Virus Nonstructural 5A Protein Inhibits Lipopolysaccharide-Mediated Apoptosis of Hepatocytes by Decreasing Expression of Toll-Like Receptor 4
- (2011) Ryo Tamura et al. JOURNAL OF INFECTIOUS DISEASES
- Hepatocellular Carcinoma
- (2011) Hashem B. El-Serag NEW ENGLAND JOURNAL OF MEDICINE
- Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis
- (2010) Salomé González-Reyes et al. BMC CANCER
- Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence
- (2010) Salomé González-Reyes et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis
- (2010) Shin Maeda Gastroenterology Research and Practice
- In situ Stimulation of CD40 and Toll-like Receptor 3 Transforms Ovarian Cancer-Infiltrating Dendritic Cells from Immunosuppressive to Immunostimulatory Cells
- (2009) U. K. Scarlett et al. CANCER RESEARCH
- Overview of the Molecular Bases of Resistance to Chemotherapy in Liver and Gastrointestinal Tumours
- (2009) J. Marin et al. CURRENT MOLECULAR MEDICINE
- Liver expression of matrix metalloproteases and their inhibitors in hepatocellular carcinoma
- (2009) A. Altadill et al. DIGESTIVE AND LIVER DISEASE
- Toll-like receptors as targets in chronic liver diseases
- (2009) A Mencin et al. GUT
- Toll-like receptors and their role in gastrointestinal disease
- (2009) Adam G Testro et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Therapeutic Targeting of Toll-Like Receptors for Infectious and Inflammatory Diseases and Cancer
- (2009) L. A. J. O'Neill et al. PHARMACOLOGICAL REVIEWS
- Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog
- (2009) K. Machida et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Toll‐like receptors and adaptor molecules in liver disease: Update
- (2008) Ekihiro Seki et al. HEPATOLOGY
- Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis
- (2008) J. B. Swann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TLR3 and TLR4 expression in healthy and diseased human endometrium
- (2008) Svenja Allhorn et al. Reproductive Biology and Endocrinology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started